Pharmagreen Biotech (PHBI).
Pharmagreen raising the bar in the cannabis space, both in the quality of cannabis produced and the efficiency of the growing method.
The company is highly focused on the rapidly evolving CBD industry by developing supply chains for CBD hemp growers utilizing the CBD Dana hemp strain.
Pharmagreen's model is to provide the hemp farmers the highest quality starter female plantlets to produce the highest quality biomass for the production of CBD formulations for human and animal use.
Pharmagreen's ability to supply high CBD starter plantlets paired with high level of expertise in farming the strain provides a very lucrative high CBD hemp farming opportunity for the farmers by making highly efficient use of land.
For example, greater profits and higher yields can be generated from 10 acres with Pharmagreen's high CBD strain and farming techniques than from farming 1,000 acres using standard industrial hemp from seed. The end product using Pharmagreen's CBD strain and farming techniques ultimately provides the highest quality, medical grade, flower tops biomass.
Pharmagreen’s proprietary method generates harvest yields a HUNDRED times better than standard industrial hemp from seed. Multiply that by the current spot price for a kilo of CBD product and consider the market opportunity.
Pharmagreen's mission is to advance the technology of cannabis tissue culture science and to provide the highest quality, 100% germ free, disease free and all genetically identical plantlets of cannabis and other flora while offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various cannabis and horticulture plants; extraction of botanical oils, mainly CBD oil, and to deliver laboratory based services to the North American Cannabis and agriculture sectors.
8 Enormous Catalysts Pharmagreen Is Focused On
The Cannabis/Botany Biotech Centre will employ between 80-100 persons on site.
This pioneering micro-propagation technology developed by B.R.I.M. allows for large-scale production.
Application of this industry-leading botanical tissue culture technology may also be adapted for any plant species.
Cold storage capacity will provide for long term plant tissue sample preservation and banking of specific live plantlet strains for future research and production.
Energy efficient and state-of-the-art greenhouse space will further allow for year-round nurseries safeguarding cultured and developing plants for all growing seasons.
B.R.I.M. has developed a proprietary industrial hemp strain named “CBD DANA” which contains a high cannabidiol content of 10-20%, less than 0.3% THC and a unique profile of active terpene and alkamide entourage constituents.
Onsite research and development will continue to enhance existing micro-propagation techniques for cultured plantlets and help refine developing protocols for a variety of Cannabis strains for indoor and outdoor cannabis growers.
The Cannabis/Botany Biotech Centre will provide analytic services, genomic characterization and testing of botanical material for industry certification and also include commercial-scale plant distillation and extraction capacity for producing botanical oils and other active medicinal constituents.
5 Services Pharmagreen Offers To Dominate The Market!
The Pharmagreen Botany Centre is dedicated to breaking boundaries to become the most internationally recognized and valued biotech science solutions company in North America for its proprietary micro-propagation techniques, tissue culture plantlets production, research and development for plants sustainability, preservation of genetics, extraction of botanical oils, Cannabis products development and plant DNA species identification and certification centre.
Market Data 
Markets 
AI
